Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HEXA | P06865 | 4/20 | 0.36 |
| ▸ | HEXB | P07686 | 4/20 | 0.36 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | OGA | O60502 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22182069 | 0.92 | CA12 (0.37) | LPAR2POLBCA12CA1CA2 | |
| SCHEMBL22182093 | 0.81 | SIRT1 (0.54) | HEXAHEXBSIRT1LPAR2POLB | |
| SCHEMBL22181838 | 0.79 | HDAC3 (0.35) | HEXAHEXBSIRT1POLBOGA | |
| SCHEMBL22182116 | 0.77 | TP53 (0.44) | HEXAHEXBSIRT1POLBALDH1A1 | |
| SCHEMBL22182014 | 0.76 | HEXA (0.36) | HEXAHEXBSIRT1POLBOGA | |
| SCHEMBL22182076 | 0.76 | ALDH1A1 (0.48) | HEXAHEXBSIRT1LPAR2POLB | |
| SCHEMBL22182108 | 0.74 | USP2 (0.41) | HEXAHEXBSIRT1POLBOGA | |
| SCHEMBL22182098 | 0.69 | SIRT1 (0.57) | HEXAHEXBSIRT1LPAR2POLB | |
| SCHEMBL22181854 | 0.69 | SIRT1 (0.57) | HEXAHEXBSIRT1POLBOGA | |
| SCHEMBL22181859 | 0.69 | HEXA (0.63) | HEXAHEXBSIRT1POLBOGA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020139291-A1 | NAPHTHALIMIDE DERIVATIVES AS ANTI-PARASITIC AGENTS FOR THE TREATMENT OF LEISHMANIASIS AS WELL AS VIRAL, BACTERIAL AND NEOPLASTIC DISEASES | ISTANBUL MEDIPOL UNIVERSITESI (TR) | 2020-07-02 | — | — | WO | disclosed |